2015 Q1 Form 10-Q Financial Statement
#000114420415031656 Filed on May 15, 2015
Income Statement
Concept | 2015 Q1 | 2014 Q1 |
---|---|---|
Revenue | $41.79K | $509.4K |
YoY Change | -91.8% | -45.36% |
Cost Of Revenue | $10.00K | $367.6K |
YoY Change | -97.28% | -35.94% |
Gross Profit | $30.00K | $139.7K |
YoY Change | -78.53% | -61.02% |
Gross Profit Margin | 71.78% | 27.43% |
Selling, General & Admin | $290.0K | $300.0K |
YoY Change | -3.33% | -54.55% |
% of Gross Profit | 966.67% | 214.69% |
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $4.760K | $8.659K |
YoY Change | -45.03% | -56.45% |
% of Gross Profit | 15.87% | 6.2% |
Operating Expenses | $290.8K | $298.7K |
YoY Change | -2.62% | -55.09% |
Operating Profit | -$258.2K | -$158.9K |
YoY Change | 62.47% | -48.14% |
Interest Expense | $50.00K | $2.338K |
YoY Change | 2038.58% | -356.64% |
% of Operating Profit | ||
Other Income/Expense, Net | $51.03K | -$12.97K |
YoY Change | -493.42% | -112.36% |
Pretax Income | -$207.2K | -$171.9K |
YoY Change | 20.52% | -14.71% |
Income Tax | $956.00 | $1.206K |
% Of Pretax Income | ||
Net Earnings | -$208.1K | -$173.1K |
YoY Change | 20.23% | -14.11% |
Net Earnings / Revenue | -497.96% | -33.98% |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$308.8K | -$257.6K |
COMMON SHARES | ||
Basic Shares Outstanding | 343.8M shares | 328.9M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2015 Q1 | 2014 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $550.0K | $570.0K |
YoY Change | -3.51% | -59.57% |
Cash & Equivalents | $550.0K | $495.8K |
Short-Term Investments | $70.00K | |
Other Short-Term Assets | $120.0K | $320.0K |
YoY Change | -62.5% | -57.89% |
Inventory | $0.00 | $16.07K |
Prepaid Expenses | $100.8K | |
Receivables | $90.00K | $212.2K |
Other Receivables | $120.0K | $400.0K |
Total Short-Term Assets | $880.0K | $1.514M |
YoY Change | -41.88% | -44.74% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $10.00K | $35.19K |
YoY Change | -71.58% | -81.48% |
Goodwill | ||
YoY Change | ||
Intangibles | $4.948K | |
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $20.00K | |
YoY Change | ||
Total Long-Term Assets | $40.00K | $40.14K |
YoY Change | -0.35% | -96.71% |
TOTAL ASSETS | ||
Total Short-Term Assets | $880.0K | $1.514M |
Total Long-Term Assets | $40.00K | $40.14K |
Total Assets | $920.0K | $1.554M |
YoY Change | -40.81% | -60.75% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $120.0K | $193.1K |
YoY Change | -37.84% | -68.35% |
Accrued Expenses | $620.0K | $530.4K |
YoY Change | 16.89% | -65.33% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $10.00K | $20.00K |
YoY Change | -50.0% | -33.33% |
Total Short-Term Liabilities | $760.0K | $792.4K |
YoY Change | -4.09% | -66.28% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $10.00K |
YoY Change | -100.0% | -75.0% |
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | $10.00K |
YoY Change | -100.0% | -75.0% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $760.0K | $792.4K |
Total Long-Term Liabilities | $0.00 | $10.00K |
Total Liabilities | $764.0K | $806.4K |
YoY Change | -5.26% | -66.26% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$53.96M | -$52.26M |
YoY Change | 3.25% | |
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $160.0K | $750.0K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $920.0K | $1.550M |
YoY Change | -40.65% | -60.86% |
Cashflow Statement
Concept | 2015 Q1 | 2014 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$208.1K | -$173.1K |
YoY Change | 20.23% | -14.11% |
Depreciation, Depletion And Amortization | $4.760K | $8.659K |
YoY Change | -45.03% | -56.45% |
Cash From Operating Activities | $288.4K | -$44.99K |
YoY Change | -741.09% | -83.19% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | $90.00K |
YoY Change | -100.0% | |
Cash From Investing Activities | $0.00 | $87.48K |
YoY Change | -100.0% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $195.0K | $0.00 |
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 190.0K | -$9.981K |
YoY Change | -2003.62% | 40.68% |
NET CHANGE | ||
Cash From Operating Activities | $288.4K | -$44.99K |
Cash From Investing Activities | 0.000 | $87.48K |
Cash From Financing Activities | 190.0K | -$9.981K |
Net Change In Cash | $288.4K | $32.51K |
YoY Change | 787.31% | -111.83% |
FREE CASH FLOW | ||
Cash From Operating Activities | $288.4K | -$44.99K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2014Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
53506353 | USD |
CY2015Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-53957865 | USD |
CY2015Q1 | us-gaap |
Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
|
0 | USD |
CY2014Q4 | us-gaap |
Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
|
25000 | USD |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
120979 | USD |
CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1036125 | USD |
CY2015Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
550000000 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
550000000 | shares |
CY2015Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
343774050 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
343774050 | shares |
CY2015Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
339374050 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
339374050 | shares |
CY2015Q1 | us-gaap |
Revenues
Revenues
|
41794 | USD |
CY2014Q1 | us-gaap |
Gross Profit
GrossProfit
|
139737 | USD |
CY2014Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
298655 | USD |
CY2015Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
290830 | USD |
CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-158918 | USD |
CY2015Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-258191 | USD |
CY2014Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
2338 | USD |
CY2015Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
-280 | USD |
CY2014Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1802 | USD |
CY2015Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | USD |
CY2014Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
0 | USD |
CY2015Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
51310 | USD |
CY2014Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-12971 | USD |
CY2015Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
51030 | USD |
CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-171889 | USD |
CY2015Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-207161 | USD |
CY2014Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1206 | USD |
CY2015Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
956 | USD |
CY2014Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-173095 | USD |
CY2015Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-208117 | USD |
CY2014Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
CY2015Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
CY2014Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
328874050 | shares |
CY2015Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
341341828 | shares |
CY2014Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8659 | USD |
CY2015Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4760 | USD |
CY2014Q1 | payd |
Unrealized Gain On Investments
UnrealizedGainOnInvestments
|
-2800 | USD |
CY2015Q1 | payd |
Unrealized Gain On Investments
UnrealizedGainOnInvestments
|
0 | USD |
CY2014Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
12668 | USD |
CY2015Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
50333 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-128417 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
75 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
14761 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
0 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
59632 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-7827 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
|
2041 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
|
0 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-307269 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-94536 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
91457 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-904 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
38734 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-110 | USD |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-44993 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-288447 | USD |
CY2014Q1 | us-gaap |
Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
|
9981 | USD |
CY2015Q1 | us-gaap |
Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
|
4296 | USD |
CY2014Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2015Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
195000 | USD |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-9981 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
190704 | USD |
CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
32508 | USD |
CY2015Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-97743 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
463285 | USD |
CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
495793 | USD |
CY2014Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2015Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2014Q1 | us-gaap |
Interest Paid
InterestPaid
|
596 | USD |
CY2015Q1 | us-gaap |
Interest Paid
InterestPaid
|
280 | USD |
CY2015Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates made by the Company’s management include, but are not limited to the collectability of accounts receivables and other receivables, the valuation of inventories, the recoverability of long-lived assets, the valuation of deferred tax assets and liabilities and the estimated fair value of the royalty and advance guarantees and share-based transactions. Actual results could materially differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2015Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Reclassifications</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Certain reclassifications have been made to the prior period financial statement presentation to conform to the current year financial statement presentation. The reclassifications did not have any effect on reported net losses for any period presented.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2015Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Concentration of Credit Risk</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company maintains cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. At March 31, 2015, the Company had amounts in these accounts in excess of the FDIC limit. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to these deposits. Management believes that it has invested in high credit quality institutions for which the Company has not experienced any loss in its accounts and believes it is not exposed to any significant credit risk related to these accounts.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company extends credit based on an evaluation of the customer's financial condition, generally without requiring collateral. Exposure to losses on receivables is principally dependent on each customer's financial condition. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses. Although the Company expects to collect amounts due, actual collections may differ from the estimated amounts. At both March 31, 2015 and December 31, 2014, the Company has recorded an allowance for doubtful accounts of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">38,609</font></font>, respectively.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> For the three months ended March 31, 2015, no revenues from an individual client accounted for more than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of total revenues. For the three months ended March 31, 2014, revenues from one client accounted for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 86</font>% of total revenues. These revenues were generated from the sales of our line of AuctionInc products, tour merchandise, VIP services, and merchandising and fulfillment services.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2015Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
38609 | USD |
CY2014Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
38609 | USD |
CY2014Q1 | us-gaap |
Advertising Expense
AdvertisingExpense
|
940 | USD |
CY2015Q1 | us-gaap |
Advertising Expense
AdvertisingExpense
|
6224 | USD |
CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
11962000 | shares |
CY2015Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3535000 | shares |
CY2015Q1 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
1115 | USD |
CY2014Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
2019 | USD |
CY2015Q1 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
80572 | USD |
CY2014Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
80572 | USD |
CY2015Q1 | payd |
Stock Payment Guarantee Liabilities Current
StockPaymentGuaranteeLiabilitiesCurrent
|
503422 | USD |
CY2014Q4 | payd |
Stock Payment Guarantee Liabilities Current
StockPaymentGuaranteeLiabilitiesCurrent
|
554732 | USD |
CY2015Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
36696 | USD |
CY2014Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
36696 | USD |
CY2015Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
621805 | USD |
CY2014Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
674019 | USD |
CY2015Q1 | us-gaap |
Other Receivables
OtherReceivables
|
120338 | USD |
CY2014Q4 | us-gaap |
Other Receivables
OtherReceivables
|
120338 | USD |
CY2015Q1 | us-gaap |
Liabilities
Liabilities
|
763990 | USD |
CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
915146 | USD |
CY2014Q1 | us-gaap |
Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
|
2800 | USD |
CY2015Q1 | us-gaap |
Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
|
0 | USD |
CY2014Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
87482 | USD |
CY2015Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
|
0 | USD |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
87482 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
0 | USD |
CY2015Q1 | us-gaap |
Share Price
SharePrice
|
0.12 | |
CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2015Q1 | us-gaap |
Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
|
less than a 50% likelihood | |
CY2015Q1 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
19702 | USD |
CY2014Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
23387 | USD |
CY2014Q1 | us-gaap |
Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
|
3748 | USD |
CY2015Q1 | us-gaap |
Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
|
0 | USD |
CY2014Q1 | payd |
Other Accounts Receivable Writeoffs
OtherAccountsReceivableWriteoffs
|
55618 | USD |
CY2015Q1 | payd |
Other Accounts Receivable Writeoffs
OtherAccountsReceivableWriteoffs
|
0 | USD |
CY2014Q1 | us-gaap |
Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
|
3748 | USD |
CY2015Q1 | us-gaap |
Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
|
0 | USD |
CY2015Q1 | us-gaap |
Fdic Indemnification Asset
FDICIndemnificationAsset
|
250000 | USD |
CY2015Q1 | payd |
Common Stock Held For Sale
CommonStockHeldForSale
|
2528091 | shares |
CY2014Q4 | payd |
Common Stock Held For Sale
CommonStockHeldForSale
|
2528091 | shares |
CY2015Q1 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | USD |
CY2014Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | USD |
CY2014Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
55618 | USD |
CY2015Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
0 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-214759 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
0 | USD |
CY2014Q1 | us-gaap |
Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
|
0 | USD |
CY2015Q1 | us-gaap |
Increase Decrease In Other Deposits
IncreaseDecreaseInOtherDeposits
|
3685 | USD |
CY2015Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
500000 | shares |
CY2014Q1 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
CY2015Q1 | us-gaap |
Stock Issued1
StockIssued1
|
25000 | USD |
CY2015Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
195000 | USD |
CY2015Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
288447 | USD |
CY2014Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD |
CY2015Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | USD |
CY2014Q4 | us-gaap |
Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
|
500000 | shares |